Rapports de pénurie pour SANDOZ CANADA INCORPORATED
Nom de l’entreprise
SANDOZ CANADA INCORPORATED
Total rapports |
||
Rapports de pénurie |
2244 |
|
| Pénurie réelle: | 44 (2%) | |
| Pénurie prévue: | 0 (0%) | |
| Pénurie évitée: | 19 (1%) | |
| Résorbée: | 2181 (97%) | |
Rapports de cessation de vente |
121 |
|
| Discontinué sous peu: | 7 (6%) | |
| Discontinué: | 112 (93%) | |
| Renversé: | 2 (2%) | |
Rapports en retard |
448 (19%) |
|
Rapports expirés |
11 (22%) |
|
Rapports de pénurie
| Nom de marque | Concentration(s) | Posologie | État | Date de création | Dernière mise à jour | Rapports |
|---|---|---|---|---|---|---|
| MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Liquide | Résorbée | 2021-11-04 | 2022-08-05 | 148854 |
| MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Liquide | Résorbée | 2022-09-02 | 2023-03-06 | 168548 |
| MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Liquide | Résorbée | 2022-12-16 | 2023-03-14 | 178666 |
| MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Liquide | Résorbée | 2023-04-20 | 2023-05-03 | 189909 |
| MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Liquide | Résorbée | 2023-04-20 | 2023-05-03 | 189913 |
| MULTI 12 INJECTION | 1MCG 80MCG 12MCG 2UNIT 3MG 0.8MG 8MG 0.72MG 0.6MG 40UNIT 660UNIT 20MG | Liquide | Résorbée | 2024-01-26 | 2024-05-22 | 217399 |
| MULTI-12/K1 PEDIATRIC | 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG | Liquide | Résorbée | 2021-11-04 | 2022-01-21 | 148846 |
| MULTI-12/K1 PEDIATRIC | 400UNIT 2300UNIT 80MG 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG | Liquide | Résorbée | 2022-10-25 | 2023-05-30 | 172557 |
| MULTI-12/K1 PEDIATRIC | 1MCG 140MCG 20MCG 0.2MG 7UNIT 5MG 17MG 1MG 1.4MG 1.2MG 400UNIT 2300UNIT 80MG | Liquide | Résorbée | 2024-01-08 | 2024-02-06 | 215358 |
| MYCAMINE | 50MG | Poudre pour solution | Résorbée | 2025-02-11 | 2025-04-08 | 250175 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4MG | Liquide | Résorbée | 2017-03-21 | 2017-04-12 | 3820 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4MG | Liquide | Pénurie évitée | 2017-03-21 | 2017-06-26 | 3823 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4MG | Liquide | Résorbée | 2019-04-05 | 2019-07-08 | 80570 |
| NALOXONE HCL INJECTION - 0.4MG/ML USP | 0.4MG | Liquide | Résorbée | 2022-03-10 | 2022-04-06 | 156432 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1mg/mL | INJ | Résorbée | 2017-03-14 | 2017-06-26 | 2609 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | Liquide | Résorbée | 2019-04-05 | 2019-06-28 | 80573 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | Liquide | Résorbée | 2020-12-07 | 2021-02-16 | 129727 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | Liquide | Résorbée | 2022-10-19 | 2022-12-29 | 172174 |
| NALOXONE HCL INJECTION - 1MG/ML USP | 1MG | Liquide | Résorbée | 2023-01-19 | 2023-03-21 | 181704 |
| NOREPINEPHRINE BITARTRATE INJECTION USP | 1MG | Liquide | Résorbée | 2018-01-08 | 2018-01-18 | 35329 |
Rapports de cessation de vente
| Nom de marque | Concentration(s) | Posologie | État | Date de création | Dernière mise à jour | Rapports |
|---|---|---|---|---|---|---|
| ALFENTANIL INJECTION USP | 2ml | Discontinué | 2019-10-15 | 2019-10-15 | 96610 | |
| ATRACURIUM BESYLATE INJECTION | 10ml | Discontinué | 2019-10-15 | 2019-10-15 | 96613 | |
| BETAJECT | 1ml | Discontinué | 2019-10-15 | 2019-10-15 | 96616 | |
| BLUE COLLYRIUM | BLUE COLLYRIUM | Discontinué | 2019-10-15 | 2019-10-15 | 96619 | |
| BRETYLIUM TOSYLATE INJECTION USP | 50MG | Solution | Discontinué | 2017-12-06 | 2017-12-06 | 31958 |
| BRETYLIUM TOSYLATE INJECTION USP | 50mg/ml | Discontinué | 2020-04-01 | 2020-04-01 | 110288 | |
| CLINDAMYCIN INJECTION USP | 150MG | Liquide | Discontinué | 2017-06-06 | 2017-10-18 | 12122 |
| CODEINE PHOSPHATE INJECTION USP | 30MG | Liquide | Discontinué | 2022-04-20 | 2022-04-20 | 159064 |
| COMTAN | 200MG | Comprimé | Discontinué | 2022-03-03 | 2022-03-04 | 155940 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | Solution | Discontinué | 2018-08-27 | 2019-01-02 | 59179 |
| FOLIC ACID INJECTION USP | 5MG | Liquide | Discontinué sous peu | 2019-05-01 | 2019-05-01 | 82956 |
| FOLIC ACID INJECTION USP | 5MG | Liquide | Discontinué | 2020-01-28 | 2020-01-28 | 104481 |
| HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) | 10000UNIT | Solution | Discontinué | 2018-07-04 | 2018-07-31 | 54349 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 10000UNIT | Solution | Discontinué | 2023-10-18 | 2023-10-19 | 207275 |
| HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) | 10000UNIT | Solution | Discontinué | 2024-05-17 | 2024-05-18 | 228249 |
| IMIPENEM AND CILASTATIN FOR INJECTION USP | 250MG 250MG | Poudre pour solution | Discontinué | 2021-08-23 | 2021-08-23 | 144467 |
| KETOROLAC TROMETHAMINE INJECTION USP | 30MG | Solution Liquide | Discontinué | 2025-08-04 | 2025-08-05 | 264341 |
| LORAZÉPAM INJECTION USP | 2MG | Solution | Discontinué | 2020-02-14 | 2020-03-12 | 106265 |
| MICRO PLUS 6 (CONCENTRATE) | 75MCG 60MCG 10MCG 0.5MG 1MG 5MG | Liquide | Discontinué | 2021-10-25 | 2021-10-26 | 147927 |
| MILRINONE LACTATE INJECTION | 1MG | Solution | Discontinué | 2022-06-17 | 2022-06-18 | 163000 |